Welcome to our world. A world where all South Africans have access to world class medicines at affordable prices.
Reydin is a combination of tenofovir (TDF), lamivudine (3TC) and dolutegravir (DTG) and is approved by the South African Health Products Regulatory Authority (SAHPRA).
The contents of this page is password protected and intended for healthcare practitioners only.
Healthcare practitioners that would like to request access, please send an email to access@brand.cipla.co.za with:(1) Your full name(2) Your practitioner or practice number
